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Background
A vaccine capable of stimulating protective anti-viral anti-
body responses is needed to curtail the global Acquired
Immunodeficiency Syndrome (AIDS) epidemic caused by
HIV-1. Although rarely elicited during the course of natu-
ral infection or upon conventional vaccination, the mem-
brane proximal ectodomain region (MPER) of the HIV-1
gp41 envelope protein subunit is the target of three such
human broadly neutralizing antibodies (BNAbs): 4E10,
2F5 and Z13e1. How these BNAbs bind to their lipid-
embedded epitopes and mediate anti-viral activity are
unclear, but such information might offer important
insight into a world-wide health imperative.
Methods
Electron paramagnetic resonance (EPR) and nuclear mag-
netic resonance (NMR) techniques were used to define the
manner in which theses BNAbs differentially recognize
viral membrane-encrypted residues configured within the
L-shaped helix-hinge-helix MPER segment.
Results
Two distinct modes of antibody-mediated interference of
viral infection were identified. Both 4E10 and 2F5 induce
large conformational changes in the MPER relative to the
membrane. However, while 4E10 straddles the hinge and
extracts residues W672 and F673, 2F5 lifts up residues N-
terminal to the hinge region, exposing L669 and W670. In
contrast, Z13e1 affects little change in membrane orienta-
tion or conformation, but rather immobilizes the MPER
hinge through extensive rigidifying surface contacts.
Conclusion
We conclude that BNAbs disrupt HIV-1 MPER fusogenic
functions critical for virus entry into human CD4 T cells
and macrophages either by preventing hinge motion or by
perturbing MPER orientation. HIV-1 MPER features
important for targeted vaccine design have been revealed,
the implications of which extend to BNAb targets on other
viral fusion proteins.
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